 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.024.758 |
| Chemical and physical data | |
| Formula | C14H12O2 |
| Molar mass | 212.248 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Felbinac (INN, orbiphenylylacetic acid) is atopical medicine,[1] belonging to the family of medicines known asnonsteroidal anti-inflammatory drugs (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation andarthritis.[2] It is an active metabolite offenbufen.[3]
The α-methyl acid of felbinac is calledbiprofen and is used to preparebifepramide. The α-ethyl acid is calledxenbucin which is used to makexenthiorate.
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
 | Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it. |
